Covaxin has so far been evaluated in 1,000 participants in Phase 1 and 2 clinical trials, with the company saying that the results showed promising s…
Read moreThis is the first concrete development on the Sputnik V front since India confirmed it was in discussions to take forward the testing and manufactu…
Read moreBharat Biotech to move to phase II trials for Covaxin A candidate that raked up controversy in early July following an Indian Council of Medical …
Read moreCOVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine…
Read moreIn November 2015, the company said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites -- acti…
Read moreThe information provided here is collected from different sources. We do not take responsibility of its correctness and verification. We are merely collecting and providing you the access to this data. You are advised to use it solely on your own discretion.
Reach us on social media:
Social Plugin